Stockscreener 앱 받기
12.29
6.61%
-0.87
시간 외 거래:
12.30
0.01
+0.08%
Alpha Tau Medical Ltd 주식(DRTS)의 최신 뉴스
DRTS 6-K & SEC Filings - Yahoo! Finance Canada
Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More (ORMP) - Seeking Alpha
Is Trial Enrollment Completion Altering The Investment Case For Alpha Tau Medical (DRTS)? - simplywall.st
Is Trial Enrollment Completion Altering The Investment Case For Alpha Tau Medical (DRTS)? - simplywall.st
Alpha Tau Medical (NasdaqCM:DRTS) Stock Forecast & Analyst Predictions - Simply Wall Street
Alpha Tau Medical stock hits 52-week high at 15.11 USD By Investing.com - Investing.com Australia
Is IMPACT Pilot Enrollment Completion Reshaping The Investment Case For Alpha Tau Medical (DRTS)? - simplywall.st
Alpha Tau Medical stock hits 52-week high at 15.11 USD - Investing.com
Alpha Tau Medical stock hits 52-week high at 15.11 USD - Investing.com Canada
Alpha Tau Medical stock hits 52-week high at 15.11 USD - Investing.com Nigeria
Alpha Tau Medical stock hits 52-week high at 15.11 USD - Investing.com India
Alpha Tau Medical stock hits 52-week high at 15.11 USD - Investing.com UK
Alpha Tau: Approaching Massive Year-End; Pounding The Table On Potential GBM Breakthrough - Seeking Alpha
Alpha Tau Medical stock hits 52-week high at 15.11 USD By Investing.com - Investing.com South Africa
Alpha Tau to Participate in September Investor Conferences - Alpha Tau Medical
Alpha Tau to Participate in September Investor Conferences - The Manila Times
Alpha Tau to Participate in September Investor Conferences - Yahoo Finance
H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial enrollment By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial enrollment - Investing.com Nigeria
H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial enrollment - Investing.com
Alpha Tau Medical (DRTS) finishes pancreatic IMPACT study signup - Stock Titan
Alpha Tau’s pancreatic cancer study grows from 12 to 48 patients as enrollment closes - Stock Titan
Alpha Tau Medical Ltd. Warrant (DRTSW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Alpha Tau Medical Ltd. Warrant (DRTSW) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Alpha Tau Medical Warrant (DRTSW) Rises 4.1% to $4.05 as Support HoldsStock Picks - careplusvn.com
Enlight (ENLT) Quarterly Results: The Company Releases Its Current Earnings Data in Latest Trading; Post-Report: Shares Move 0.41% Higher on the DayEarnings Stability Report - careplusvn.com
Alpha (DRTS) Quarterly Figures: EPS Falls Short of Its Estimate in the Current Update; Stock Move: Shares Finish 1.27% Down in the Available RecordGeographic Revenue Trends - dars.gov.et
Alpha Tau Medical (DRTS) officer schedules next stock sale under 10b5-1 plan - Stock Titan
Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year HighHere's What Happened - MarketBeat
Alpha Tau Medical stock hits 52-week high at 14.79 USD - Investing.com
Alpha Tau Medical stock hits 52-week high at 14.79 USD - Investing.com Canada
Alpha Tau’s Clinical Momentum Put Its Cancer Tech On The Map - Finimize
Price to sales forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
Price to earnings forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
Alpha (DRTS) Quarter in Focus: EPS Does Not Reach the Reported Estimate; Share Response - careplusvn.com
Alpha (DRTS) Quarter in Focus: EPS Does Not Reach the Reported Estimate; Share Response - dars.gov.et
Alpha (DRTS) Quarter in Focus: EPS Does Not Reach the Reported Estimate; Share Response: Shares Finish 0.35% Lower for the Current SessionEarnings Miss Alert - dars.gov.et
Alpha (DRTS) Quarter in Focus: EPS Does Not Reach the Reported Estimate; Share Response - dars.gov.et
Price to earnings forward of Alpha Tau Medical Ltd. – BOATS:DRTSW - TradingView
Is Alpha Tau Medical’s (DRTS) Steepening Loss Curve Reframing Its High-Risk Innovation Strategy? - simplywall.st
Is Alpha Tau Medical’s (DRTS) Steepening Loss Curve Reframing Its High-Risk Innovation Strategy? - simplywall.st
Alpha Tau Medical Ltd.: Fundamental Analysis and Financial Ratings | DRTS | IL0011839383 - marketscreener.com
Alpha Tau Medical (XTAE:DRTS) Cyclically Adjusted Price-to-FCF : (As of Aug. 15, 2026) - GuruFocus
Alpha Tau Medical (XTAE:DRTS) Shiller PE Ratio : (As of Aug. 21, 2026) - GuruFocus
DRTS Forecast — Price Target — Prediction for 2027 - TradingView
Q3 EPS Estimate for Alpha Tau Medical Decreased by Analyst - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Stock Price Down 5.4% Following Insider Selling - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) CFO Sells $248,220.00 in Stock - MarketBeat
H.C. Wainwright raises Alpha Tau Medical stock price target to $16 - Investing.com
H.C. Wainwright raises Alpha Tau Medical stock price target to $16 - Investing.com Nigeria
1.60%
0.00%
자본화:
|
볼륨(24시간):